Pharma Focus Asia

Vetter invests 300 million Euro to expand and upgrade its manufacturing facilities in Germany

Introduction:

Vetter has announced to invest approximately 300 million euros to expand and upgrade its manufacturing facilities over an estimated five-year period.

Features:

The upgrades are being driven by a changing healthcare market that is affected by issues such as ever-more complex molecules, smaller batch sizes, and increasing regulatory requirements.

The first of the facility expansions are already ongoing at several of the company’s German locations including its ‘Ravensburg Vetter West’ center for visual inspection and logistics. Structural work for the facility enlargement, which will offer more than double of its current capacity, is completed with the site being on schedule to become fully operational in 2017.

magazine-slider-imageCytiva - Supor Prime filtersMFA + MMA 20244th Annual Cleaning Validation 20242nd Annual Pharma Impurity Conclave 2024CPHI Korea 2024CHEMICAL INDONESIA 2024World Orphan Drug Congress Europe 2024INALAB 2024Thermo Fisher - Drug Discovery and the impact of mAbsAdvanced Therapies USA 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals Conference